deferasirox has been researched along with Obesity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cha, KM; Cheng, K; Gunton, JE; Ho, KW; Kodsi, R; Langley, N; Laybutt, DR; Nazari, M; Stokes, RA; Swarbrick, MM; Wang, M | 1 |
1 other study(ies) available for deferasirox and Obesity
| Article | Year |
|---|---|
Iron chelation increases beige fat differentiation and metabolic activity, preventing and treating obesity.
Topics: Adipose Tissue, Beige; Animals; Cell Differentiation; Deferasirox; Diet, High-Fat; Glucose; Humans; Iron Chelating Agents; Lipid Metabolism; Mice; Obesity; Thermogenesis; Uncoupling Protein 1 | 2022 |